We are live on
!
Find out more
MAM
Myriad Asset Management Portfolio holdings
AUM
$722M
1-Year Est. Return
11.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.83%
1 Year Est. Return
+11.94%
3 Year Est. Return
+148.96%
5 Year Est. Return
+248.9%
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$201M
(-22%)
Cap. Flow
-$661M
Cap. Flow
% of AUM
-91.62%
Top 10 Holdings %
Top 10 Hldgs %
73.57%
Holding
160
New
16
Increased
6
Reduced
17
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$19.8M |
| 2 |
Pinduoduo
PDD
|
+$15.4M |
| 3 |
BP
BP
|
+$11.4M |
| 4 |
Shell
SHEL
|
+$10.3M |
| 5 |
Li Auto
LI
|
+$8.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$44.2M |
| 2 |
Freeport-McMoran
FCX
|
+$29.5M |
| 3 |
Mirion Technologies
MIR
|
+$25.4M |
| 4 |
Bank of America
BAC
|
+$22.4M |
| 5 |
Alcoa
AA
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.6% |
| 2 | Energy | 6.28% |
| 3 | Materials | 4.06% |
| 4 | Financials | 4.04% |
| 5 | Consumer Discretionary | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ConocoPhillips
COP
$157B
| $21.6M | 2.99% |
+215,740
| New | +$19.8M |
|
|
2
PUT
Li Auto
LI
$12B
| $15.5M | 2.15% |
+600,000
| New | +$16.5M |
|
|
3
Freeport-McMoran
FCX
$110B
| $15M | 2.08% |
301,900
-666,935
| -69% | -$29.5M |
|
|
4
Pinduoduo
PDD
$122B
| $12M | 1.67% |
+300,000
| New | +$15.4M |
|
|
5
PUT
Pinduoduo
PDD
$122B
| $12M | 1.67% |
+300,000
| New | +$15.4M |
|
|
6
BP
BP
$109B
| $11M | 1.52% |
+374,100
| New | +$11.4M |
|
|
7
Shell
SHEL
$250B
| $10.7M | 1.48% |
+194,100
| New | +$10.3M |
|
8
PUT
NIO
NIO
$10.9B
| $8.42M | 1.17% |
+400,000
| New | +$9.42M |
|
|
9
Alcoa
AA
$13.3B
| $7.93M | 1.1% |
88,100
-252,706
| -74% | -$18.4M |
|
|
10
Li Auto
LI
$12B
| $7.74M | 1.07% |
+300,000
| New | +$8.27M |
|
|
NGC
11
DELISTED
Northern Genesis Acquisition Corp. III
NGC
| $4.88M | 0.68% |
500,000
| – | – |
|
12
Vertex Pharmaceuticals
VRTX
$137B
| $3.68M | 0.51% |
14,100
+3,700
| +36% | +$878K |
|
|
FVIV
13
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
| $3.43M | 0.48% |
350,000
| – | – |
|
14
Nutrien
NTR
$35.1B
| $3.36M | 0.47% |
+32,300
| New | +$2.68M |
|
15
Infosys
INFY
$48.8B
| $3.13M | 0.43% |
125,800
-12,300
| -9% | -$292K |
|
16
Eli Lilly
LLY
$1.05T
| $3.12M | 0.43% |
10,900
+3,600
| +49% | +$926K |
|
17
Pfizer
PFE
$159B
| $3.08M | 0.43% |
59,500
+9,500
| +19% | +$493K |
|
18
Halozyme
HALO
$12B
| $3.07M | 0.43% |
77,000
| – | – |
|
19
Teck Resources
TECK
$34B
| $2.98M | 0.41% |
73,900
-46,111
| -38% | -$1.65M |
|
|
CHAA
20
DELISTED
Catcha Investment Corp
CHAA
| $2.94M | 0.41% |
300,000
| – | – |
|
|
CVII
21
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $2.84M | 0.39% |
289,823
-429,458
| -60% | -$4.18M |
|
|
BHVN
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.62M | 0.36% |
22,127
+7,727
| +54% | +$964K |
|
|
KAHC
23
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
| $2.46M | 0.34% |
250,000
-250,000
| -50% | -$2.44M |
|
24
Jazz Pharmaceuticals
JAZZ
$15.9B
| $2.4M | 0.33% |
15,400
+8,900
| +137% | +$1.29M |
|
|
MVLA
25
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $2.33M | 0.32% |
238,200
| – | – |
|
Similar funds
JIM
LWA
TM
LSGA
MFP
HAM
HT
MFW
Myriad Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Myriad Asset Management held 160 positions worth $722M, down 22% from $923M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Myriad Asset Management withdrew a net $661M in Q1 2022, closing 72 positions and reducing 17 holdings. Its most notable exit was Tesla, an estimated $44.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 51% a quarter earlier, followed by Energy and Materials.
Against the trend, Myriad Asset Management opened a new position in ConocoPhillips worth $21.6M.
- Myriad Asset Management's largest Q1 2022 buy was ConocoPhillips: 215,740 shares worth $21.6M.
- Myriad Asset Management added most to Jazz Pharmaceuticals in Q1 2022, an estimated $1.29M increase.
- Myriad Asset Management's biggest Q1 2022 reduction was Freeport-McMoran, cutting an estimated $29.5M.
- Myriad Asset Management fully exited Tesla in Q1 2022, selling an estimated $44.2M.
- Myriad Asset Management's ten largest holdings make up 74% of its $722M portfolio in Q1 2022.
- Myriad Asset Management opened 16 new positions and closed 72 in Q1 2022.
- Myriad Asset Management's portfolio value fell 22% quarter-over-quarter to $722M.
Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.